Report Code : CVMI080503 | Published Date : May 8, 2025
1. Market Overview
The global bovine vaccines market is projected to grow from 1.8 billion in 2024 to 3.4 billion by 2030, at an 8.9% CAGR, driven by rising zoonotic disease threats (e.g., lumpy skin disease, FMD) and mRNA vaccine breakthroughs.
Market Segmentation
By Vaccine Type
- Live Attenuated Vaccines (XX% share): Dominant due to cost-effectiveness.
- mRNA Vaccines (Fastest-growing at 22% CAGR): Pfizer’s BOVILIS® platform leads.
- Subunit & DNA Vaccines: Gaining traction for safety in pregnant cattle.
By Disease Indication
- Foot-and-Mouth Disease (FMD) (XX% share): Outbreaks in Asia/Africa drive demand.
- Bovine Respiratory Disease (BRD) (XX% share): #1 cause of feedlot mortality.
- Lumpy Skin Disease (LSD): 2023 outbreaks in India spurred emergency vaccination.
By Geography
- North America (35% share): Advanced herd health programs.
- Asia-Pacific (Fastest-growing at 12% CAGR): LSD and FMD outbreaks in India/Vietnam.
- Africa: AU’s Pan-African Vaccine Initiative targets 60% cattle vaccination by 2030.
2. Key Growth Drivers
Zoonotic Disease Threats
- Lumpy Skin Disease: 2023 outbreak in India infected 2.4M cattle, costing $1.2B in losses.
- FMD Resurgence: New strains (e.g., O/ME-SA/PanAsia) evade traditional vaccines.
mRNA Vaccine Revolution
- Pfizer’s BOVILIS® mRNA FMD Vaccine:
- 95% efficacy in field trials (vs. 70% for conventional vaccines).
- Single-dose protection, reducing labor costs.
- Zoetis’s BRD mRNA Vaccine: Targets Mannheimia haemolytica, cuts feedlot deaths by 40%.
Government & NGO Initiatives
- EU’s “One Health” Program: Funds $500M for livestock vaccine R&D (2024-2030).
- India’s LSD Eradication Plan: Mandates free vaccination for 80M cattle by 2026.
3. Competitive Landscape
|
Company |
Innovation |
Market Impact |
|
Zoetis |
mRNA BRD vaccine (40% mortality reduction) |
Launched in U.S. feedlots (2025). |
|
Boehringer |
LSD DNA vaccine (1-dose lifetime immunity) |
AU partnership for Africa rollout. |
|
Hester Biosciences |
Heat-stable FMD vaccine (no cold chain needed) |
Adopted in 15 African nations. |
4. Future Outlook (2025-2031)
- 2026: First self-amplifying mRNA vaccines enter trials.
- 2028: Needle-free nasal vaccines for BRD to capture 20% market share.
- 2030: Africa to vaccinate 60% of cattle under AU’s plan.
Reasons To Buy
Scope
Key Players
- Zoetis Inc.
- Merck & Co. Inc.
- Boehringer Ingelheim
- Elanco Animal Health
- Ceva Santé Animale
- Virbac
- Indian Immunologicals Ltd.
- Hester Biosciences
- Vaxxinova
- Bimeda Animal Health
| 1. Global Bovine Vaccines Market Research Report |
| 1.1 Study Objectives |
| 1.2 Global Bovine Vaccines Market - Overview |
| 1.3 Reason to Read This Report |
| 1.4 Methodology and Forecast Analysis |
| 2. Global Bovine Vaccines Market Research Report - Preface |
| 2.1 Global Bovine Vaccines Market Research Report – Detailed Scope and Definitions |
| 2.1.1 By Type |
| 2.1.2 By Disease |
| 2.1.3 By Application |
| 2.1.4 By Administration Route |
| 2.1.5 By Distribution Channel |
| 2.1.6 By End User |
| 2.1.7 By Region |
| 2.1.8 By Region |
| 3. Global Bovine Vaccines Market Dynamics |
| 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers |
| 3.2. Restraints – By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, By Country |
| 3.3. Opportunities – By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, By Country |
| 3.4. Trends – By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, By Country |
| 3.5. PEST Analysis |
| 3.6. Porters Five Rule Analysis |
| 3.7. Company’s Share Analysis (CSA) by Region or By Country |
| 3.8. Global Bovine Vaccines Market Research Report – DROTs Impact Analysis |
| 4. Global Bovine Vaccines Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031 |
| 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%) |
| 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031 |
| 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5. Global Bovine Vaccines Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 5.1 Inactivated Vaccines 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.2 Live Attenuated Vaccines 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.3 Toxoid Vaccines 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.4 Recombinant Vaccines 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.5 DNA Vaccines 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.6 Subunit Vaccines 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.7 Others 5.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6. Global Bovine Vaccines Market, By Disease, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 6.1 Foot & Mouth Disease 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.2 Bovine Respiratory Disease 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.3 Bovine Viral Diarrhea 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.4 Brucellosis 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.5 Clostridial Diseases 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.6 Mastitis 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.7 Others 6.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7. Global Bovine Vaccines Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 7.1 Preventive 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.2 Therapeutic 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.3 Diagnostic 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.4 Research 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.5 Others 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8. Global Bovine Vaccines Market, By Administration Route, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 8.1 Injection 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.2 Oral 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.3 Nasal 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.4 Topical 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.5 Others 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9. Global Bovine Vaccines Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 9.1 Veterinary Hospitals 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.2 Retail Pharmacies 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.3 Online Platforms 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.4 Veterinary Clinics 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.5 Others 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10. Global Bovine Vaccines Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 10.1 Dairy Farms 10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.2 Beef Farms 10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.3 Veterinary Clinics 10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.4 Government Organizations 10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.5 Research Institutes 10.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11. Global Bovine Vaccines Market, By Region, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 11.1 North America 11.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.2 Europe 11.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.3 Asia-Pacific 11.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.4 Latin America 11.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.5 Middle East & Africa. 11.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12. Global Bovine Vaccines Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) |
| 12.1 North America |
| 12.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.2 Europe |
| 12.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.3 Asia-Pacific |
| 12.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.4 Latin America |
| 12.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.5 Middle East & Africa |
| 12.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.6 Global Bovine Vaccines Market - Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Region, 2024 - 2031 |
| 13. North America Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.1.1 Inactivated Vaccines |
| 13.1.2 Live Attenuated Vaccines |
| 13.1.3 Toxoid Vaccines |
| 13.1.4 Recombinant Vaccines |
| 13.1.5 DNA Vaccines |
| 13.1.6 Subunit Vaccines |
| 13.1.7 Others |
| 13.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.2.1 Foot & Mouth Disease |
| 13.2.2 Bovine Respiratory Disease |
| 13.2.3 Bovine Viral Diarrhea |
| 13.2.4 Brucellosis |
| 13.2.5 Clostridial Diseases |
| 13.2.6 Mastitis |
| 13.2.7 Others |
| 13.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.3.1 Preventive |
| 13.3.2 Therapeutic |
| 13.3.3 Diagnostic |
| 13.3.4 Research |
| 13.3.5 Others |
| 13.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.4.1 Injection |
| 13.4.2 Oral |
| 13.4.3 Nasal |
| 13.4.4 Topical |
| 13.4.5 Others |
| 13.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.5.1 Veterinary Hospitals |
| 13.5.2 Retail Pharmacies |
| 13.5.3 Online Platforms |
| 13.5.4 Veterinary Clinics |
| 13.5.5 Others |
| 13.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.6.1 Dairy Farms |
| 13.6.2 Beef Farms |
| 13.6.3 Veterinary Clinics |
| 13.6.4 Government Organizations |
| 13.6.5 Research Institutes |
| 13.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.7.1 North America |
| 13.7.2 Europe |
| 13.7.3 Asia-Pacific |
| 13.7.4 Latin America |
| 13.7.5 Middle East & Africa. |
| 13.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.8.1 United States |
| 13.8.2 Canada |
| 13.9 North America Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 13.10 Regional Trends Analysis |
| 13.11 North America Global Bovine Vaccines Market Research Report - Company Profiles |
| 13.11.1 Company 1 (United States) |
| 13.11.2 Company 2 (Canada) |
| 13.11.3 Company 3 (Canada) |
| 14. Europe Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.1.1 Inactivated Vaccines |
| 14.1.2 Live Attenuated Vaccines |
| 14.1.3 Toxoid Vaccines |
| 14.1.4 Recombinant Vaccines |
| 14.1.5 DNA Vaccines |
| 14.1.6 Subunit Vaccines |
| 14.1.7 Others |
| 14.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.2.1 Foot & Mouth Disease |
| 14.2.2 Bovine Respiratory Disease |
| 14.2.3 Bovine Viral Diarrhea |
| 14.2.4 Brucellosis |
| 14.2.5 Clostridial Diseases |
| 14.2.6 Mastitis |
| 14.2.7 Others |
| 14.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.3.1 Preventive |
| 14.3.2 Therapeutic |
| 14.3.3 Diagnostic |
| 14.3.4 Research |
| 14.3.5 Others |
| 14.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.4.1 Injection |
| 14.4.2 Oral |
| 14.4.3 Nasal |
| 14.4.4 Topical |
| 14.4.5 Others |
| 14.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.5.1 Veterinary Hospitals |
| 14.5.2 Retail Pharmacies |
| 14.5.3 Online Platforms |
| 14.5.4 Veterinary Clinics |
| 14.5.5 Others |
| 14.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.6.1 Dairy Farms |
| 14.6.2 Beef Farms |
| 14.6.3 Veterinary Clinics |
| 14.6.4 Government Organizations |
| 14.6.5 Research Institutes |
| 14.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.7.1 North America |
| 14.7.2 Europe |
| 14.7.3 Asia-Pacific |
| 14.7.4 Latin America |
| 14.7.5 Middle East & Africa. |
| 14.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.8.1 Germany |
| 14.8.2 United Kingdom |
| 14.8.3 France |
| 14.8.4 Spain |
| 14.8.5 Italy |
| 14.8.6 Russia |
| 14.8.7 Netherlands |
| 14.8.8 Poland |
| 14.8.9 Rest of Europe |
| 14.9 Europe Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 14.10 Regional Trends Analysis |
| 14.11 Europe Global Bovine Vaccines Market Research Report - Company Profiles |
| 14.11.1 Company 1 (Germany) |
| 14.11.2 Company 2 (United Kingdom) |
| 14.11.3 Company 3 (United Kingdom) |
| 15. Asia-Pacific Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 15.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.1.1 Inactivated Vaccines |
| 15.1.2 Live Attenuated Vaccines |
| 15.1.3 Toxoid Vaccines |
| 15.1.4 Recombinant Vaccines |
| 15.1.5 DNA Vaccines |
| 15.1.6 Subunit Vaccines |
| 15.1.7 Others |
| 15.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.2.1 Foot & Mouth Disease |
| 15.2.2 Bovine Respiratory Disease |
| 15.2.3 Bovine Viral Diarrhea |
| 15.2.4 Brucellosis |
| 15.2.5 Clostridial Diseases |
| 15.2.6 Mastitis |
| 15.2.7 Others |
| 15.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.3.1 Preventive |
| 15.3.2 Therapeutic |
| 15.3.3 Diagnostic |
| 15.3.4 Research |
| 15.3.5 Others |
| 15.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.4.1 Injection |
| 15.4.2 Oral |
| 15.4.3 Nasal |
| 15.4.4 Topical |
| 15.4.5 Others |
| 15.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.5.1 Veterinary Hospitals |
| 15.5.2 Retail Pharmacies |
| 15.5.3 Online Platforms |
| 15.5.4 Veterinary Clinics |
| 15.5.5 Others |
| 15.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.6.1 Dairy Farms |
| 15.6.2 Beef Farms |
| 15.6.3 Veterinary Clinics |
| 15.6.4 Government Organizations |
| 15.6.5 Research Institutes |
| 15.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.7.1 North America |
| 15.7.2 Europe |
| 15.7.3 Asia-Pacific |
| 15.7.4 Latin America |
| 15.7.5 Middle East & Africa. |
| 15.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.8.1 China |
| 15.8.2 Japan |
| 15.8.3 India |
| 15.8.4 South Korea |
| 15.8.5 Australia & NZ |
| 15.8.6 ASEAN |
| 15.8.7 Rest of Asia-Pacific |
| 15.9 Asia-Pacific Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 15.10 Regional Trends Analysis |
| 15.11 Asia-Pacific Global Bovine Vaccines Market Research Report - Company Profiles |
| 15.11.1 Company 1 (China) |
| 15.11.2 Company 2 (Japan) |
| 15.11.3 Company 3 (Japan) |
| 16. Latin America Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 16.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.1.1 Inactivated Vaccines |
| 16.1.2 Live Attenuated Vaccines |
| 16.1.3 Toxoid Vaccines |
| 16.1.4 Recombinant Vaccines |
| 16.1.5 DNA Vaccines |
| 16.1.6 Subunit Vaccines |
| 16.1.7 Others |
| 16.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.2.1 Foot & Mouth Disease |
| 16.2.2 Bovine Respiratory Disease |
| 16.2.3 Bovine Viral Diarrhea |
| 16.2.4 Brucellosis |
| 16.2.5 Clostridial Diseases |
| 16.2.6 Mastitis |
| 16.2.7 Others |
| 16.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.3.1 Preventive |
| 16.3.2 Therapeutic |
| 16.3.3 Diagnostic |
| 16.3.4 Research |
| 16.3.5 Others |
| 16.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.4.1 Injection |
| 16.4.2 Oral |
| 16.4.3 Nasal |
| 16.4.4 Topical |
| 16.4.5 Others |
| 16.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.5.1 Veterinary Hospitals |
| 16.5.2 Retail Pharmacies |
| 16.5.3 Online Platforms |
| 16.5.4 Veterinary Clinics |
| 16.5.5 Others |
| 16.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.6.1 Dairy Farms |
| 16.6.2 Beef Farms |
| 16.6.3 Veterinary Clinics |
| 16.6.4 Government Organizations |
| 16.6.5 Research Institutes |
| 16.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.7.1 North America |
| 16.7.2 Europe |
| 16.7.3 Asia-Pacific |
| 16.7.4 Latin America |
| 16.7.5 Middle East & Africa. |
| 16.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.8.1 Brazil |
| 16.8.2 Mexico |
| 16.8.3 Argentina |
| 16.8.4 Peru |
| 16.8.5 Colombia |
| 16.8.6 Rest of Latin America |
| 16.9 Latin America Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 16.10 Regional Trends Analysis |
| 16.11 Latin America Global Bovine Vaccines Market Research Report - Company Profiles |
| 16.11.1 Company 1 (Brazil) |
| 16.11.2 Company 2 (Mexico) |
| 16.11.3 Company 3 (Mexico) |
| 17. Middle East & Africa Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 17.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.1.1 Inactivated Vaccines |
| 17.1.2 Live Attenuated Vaccines |
| 17.1.3 Toxoid Vaccines |
| 17.1.4 Recombinant Vaccines |
| 17.1.5 DNA Vaccines |
| 17.1.6 Subunit Vaccines |
| 17.1.7 Others |
| 17.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.2.1 Foot & Mouth Disease |
| 17.2.2 Bovine Respiratory Disease |
| 17.2.3 Bovine Viral Diarrhea |
| 17.2.4 Brucellosis |
| 17.2.5 Clostridial Diseases |
| 17.2.6 Mastitis |
| 17.2.7 Others |
| 17.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.3.1 Preventive |
| 17.3.2 Therapeutic |
| 17.3.3 Diagnostic |
| 17.3.4 Research |
| 17.3.5 Others |
| 17.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.4.1 Injection |
| 17.4.2 Oral |
| 17.4.3 Nasal |
| 17.4.4 Topical |
| 17.4.5 Others |
| 17.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.5.1 Veterinary Hospitals |
| 17.5.2 Retail Pharmacies |
| 17.5.3 Online Platforms |
| 17.5.4 Veterinary Clinics |
| 17.5.5 Others |
| 17.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.6.1 Dairy Farms |
| 17.6.2 Beef Farms |
| 17.6.3 Veterinary Clinics |
| 17.6.4 Government Organizations |
| 17.6.5 Research Institutes |
| 17.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.7.1 North America |
| 17.7.2 Europe |
| 17.7.3 Asia-Pacific |
| 17.7.4 Latin America |
| 17.7.5 Middle East & Africa. |
| 17.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.8.1 Saudi Arabia |
| 17.8.2 UAE |
| 17.8.3 South Africa |
| 17.8.4 Egypt |
| 17.8.5 Israel |
| 17.8.6 Rest of Middle East and Africa |
| 17.9 Middle East & Africa Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 17.10 Regional Trends Analysis |
| 17.11 Middle East & Africa Global Bovine Vaccines Market Research Report - Company Profiles |
| 17.11.1 Company 1 (Saudi Arabia) |
| 17.11.2 Company 2 (UAE) |
| 17.11.3 Company 3 (UAE) |
| 18. Competition Landscape |
| 18.1 Strategic Dashboard of Top Market Players |
| 18.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis) |
| 18.2.1 Zoetis Inc. |
| 18.2.2 Merck & Co. Inc. |
| 18.2.3 Boehringer Ingelheim |
| 18.2.4 Elanco Animal Health |
| 18.2.5 Ceva Santé Animale |
| 18.2.6 Virbac |
| 18.2.7 Indian Immunologicals Ltd. |
| 18.2.8 Hester Biosciences |
| 18.2.9 Vaxxinova |
| 18.2.10 Bimeda Animal Health |
| 19. Data Collection Method and Research Approach |
| 20. Principal Presumptions and Acronyms |
